CPOINT Capital buying at Conavi Medical (CNVI)
CPOINT Capital Corp., a 10% Holder, acquired 625,000 Common Shares on a direct ownership basis at a price of $0.400 on April 23rd, 2025. The insider also acquired 1,250,000 Common Shares on an indirect ownership basis for registered holder Juno Pharmaceuticals LP at the same price. This represents a $750,000 investment into the company's shares and an account share holdings change of greater than 100%.
Let the insiders guide you to opportunity at Canadianinsider.com.
This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.